Jackson D, et al. Real-world oral glucocorticoid-sparing effect of benralizumab in severe asthma. PA2527. ERS 2019, 30 sept, Madrid, Spanje.
Studie-update: immuuntherapie bij mNSCLC
mei 2024 | Immuuntherapie, Longoncologie
nov 2021 | Astma
nov 2023
mei 2023
nov 2022